Target intelligence / Profile preview

Thermal ablation-induced coagulative necrosis (of tumor tissue)

Molecular classification
Other
01

Overview

Thermal ablation of tumor tissue via coagulative necrosis" is not a molecular target, receptor, or protein, but rather a therapeutic process used in cancer treatment. This method involves applying high temperatures (typically above 60°C) directly to tumors using modalities such as radiofrequency ablation (RFA), microwave ablation, or high-intensity focused ultrasound (HIFU). The elevated temperature causes rapid denaturation of proteins and disruption of cell membranes, leading to coagulative necrosis—a form of cell death where the basic architecture of dead tissue is preserved for several days. This process destroys cancer cells within the targeted area while aiming to spare surrounding healthy tissues as much as possible[5][7][9]. The effectiveness and extent of coagulation depend on factors like tissue type, vascularity, and electrical conductivity[1]. While highly effective for certain localized tumors and minimally invasive compared with surgery, it is not itself a druggable target but rather an endpoint or effect achieved by various energy-based devices. Note: This entry does not correspond to a canonical molecular target such as a receptor or enzyme; it describes an outcome/process. Therefore, "is_target" should be marked false and "is_incorrect" true for purposes requiring structured molecular target data.

Other names
Thermal ablation of tumor tissue via coagulative necrosisCoagulative necrosis induced by thermal ablation
02

Biological functions

Cell death
03

Disease associations

Cancer
04

Safety considerations

Damage to surrounding healthy tissues due to heat spread[1][3]Incomplete tumor destruction if insufficient heat is delivered[1][3]Potential for local recurrence if margins are not adequately treated[1][3]

Beyond the preview

Go deeper on Thermal ablation-induced coagulative necrosis (of tumor tissue).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thermal ablation-induced coagulative necrosis (of tumor tissue).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call